Skip to main content

Table 1 Total proteins detected in LC-MS of serum and tissue purified histories of normal and tumour samples

From: A novel method for isolation of histones from serum and its implications in therapeutics and prognosis of solid tumours

Proteins

Tissue normal

Tissue tumour

Serum normal

Serum tumour

Histones

H2A type 1 (91.5%)

H2A type 2-A (91.5%)

H2A type 1-C (91.5%)

H2A type 1-F (86.1%)

H2B type 1E (91.5%)

H2B type 1C (91.5%)

H3.1 (99.2%)

H4 (59.2%)

H2A type 2-A (98.4%)

H2A type 1-C (98.4%)

H2B type 1E (98%)

H3.1 (99.2%)

H4 (98.4%)

H2A type 2-A (81.5%)

H2A type 1 (74.62%)

H2A type 1-C (50%)

H3.1 (59.2%)

H2B type 1E (57%)

H4 (60%)

H2A type 2-A (46.9%)

H2A type 1-C (33%)

H2A type 1-F (38.4%)

H2A type 1-E (30%)

H2A type 1 (33%)

H2A type 4 (33%)

H2B type 1E (57%)

H2B type 1C (35%)

H3.1 (40.7%)

H4 (47%)

Non-histones

Prelamin A/C (26%)

KDM5D (274%)

ESF1 (30.6%)

ESF1 homolog (23.9%)

Acid-sensing ion channel 5 (12.9%)

Prelamin A/C (62.4%)

KDM5D (30.32%)

EIF2S3Y (29.8%)

ESF1 homolog (41%)

Acid-sensing ion channel (17.9%)

Ribonuclease UK114

Fibrinogen beta chain (65.75%)

Fibrinogen alpha chain (56.91%)

Isoform 2 of Fibrinogen alpha (69.45%)

Isoform 2 of Fibrinogen beta chain (70.96%)

Translation initiation factor elf-2B (46.1%)

Fertuin-B (47.6%)

Putative pheromone receptor (18.7%)

Fibrinogen beta chain (65.3%)

Fibrinogen alpha chain (43.3%)

Isoform 2 of Fibrinogen beta chain (67.4%)

Isoform 2 of Fibrinogen alpha chain (59.6%)

Matrix estracellular phosphoglycoprotein (60%)

Potassium voltage-gated channel subfamily C member 2 (30.8%)

ESF1 homolog (57.9%)

Alkaline phosphatase (57%)

Indoleamine 2.3-dioxygenase 1 (37.8%)

Aldehyde oxidase 2 (29.6%)

Astrocytic phosphoprotein (69.9%)

Transcription factor YY2 (32.9%)

Cannabinoid receptor 1 (11.1%)

Putative pheromone receptor (19.1%)